Gilead Sciences EVP General Counsel Keeley M. Cain Wettan filed a Form 4 on November 9, 2026, disclosing the sale of 3,399 shares of common stock on November 6, 2026, under a pre-established Rule 10b5-1 trading plan.
Key Highlights
- Reporting person: Keeley M. Cain Wettan, EVP General Counsel, Legal and Compliance at Gilead Sciences, Inc. (NASDAQ:GILD)
- Transaction: 3,399 shares of common stock disposed of (transaction code S) on November 6, 2026
- Sale price: $164.11 per share
- Remaining holdings: 5,360 shares of common stock held directly following the transaction
- Trading plan: The sale was made pursuant to a Rule 10b5-1 trading plan adopted on August 7, 2026
- Filing signed: By Amy Kim by Power of Attorney for Keeley M. Cain Wettan, dated November 9, 2026
Gilead Sciences EVP Discloses Planned Share Sale Under 10b5-1 Plan
According to the Form 4 filed with the U.S. Securities and Exchange Commission, Keeley M. Cain Wettan, Executive Vice President, General Counsel, Legal and Compliance at Gilead Sciences, Inc. (NASDAQ:GILD), disposed of 3,399 shares of Gilead common stock on November 6, 2026, at a price of $164.11 per share. The filing indicates the transaction was a direct sale (transaction code S) and that ownership following the transaction remained direct.
The filing discloses that the transaction was executed pursuant to a Rule 10b5-1 trading plan that Cain Wettan adopted on August 7, 2026. Rule 10b5-1 plans allow corporate insiders to establish pre-scheduled trading arrangements at a time when they are not in possession of material non-public information. The Form 4 indicates the applicable checkbox confirming this plan was checked by the filer.
Following the reported sale, the filing states that Cain Wettan directly beneficially owns 5,360 shares of Gilead common stock. No derivative securities transactions were reported in Table II of the filing. The form was signed by Amy Kim by Power of Attorney for Keeley M. Cain Wettan and filed on November 9, 2026.
What Was Disclosed
Gilead Sciences EVP General Counsel Keeley M. Cain Wettan reported the sale of 3,399 shares of common stock at $164.11 per share on November 6, 2026, under a Rule 10b5-1 plan adopted August 7, 2026, leaving a direct beneficial ownership of 5,360 shares.



Please wait processing your request...